Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Brian H Ramnaraign"'
Autor:
Emily J. Cicali, Elizabeth Eddy, Yan Gong, Amanda L. Elchynski, Kim Pena del Aguila, Tala Basha, Karen C. Daily, Lauren Dickson, Steven Fischer, Erin Hastings‐Monari, Dennie Jones Jr., Brian H. Ramnaraign, David L. DeRemer, Thomas J. George, Rhonda M. Cooper‐DeHoff
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 7, Pp n/a-n/a (2024)
Abstract The University of Florida Health conducted a pragmatic implementation of a pharmacogenetics (PGx) panel‐based test to guide medications used for supportive care prescribed to patients undergoing chemotherapy. The implementation was in the
Externí odkaz:
https://doaj.org/article/6ba77f494cb54183b06d4c9b1083c926
Autor:
Brian H Ramnaraign, Ji-Hyun Lee, Azka Ali, Sherise C Rogers, Jesus C Fabregas, Ryan M Thomas, Carmen J Allegra, Ilyas Sahin, David L DeRemer, Thomas J George, Jonathan A Chatzkel
Publikováno v:
Future Oncology. 18:3815-3822
Immune checkpoint inhibitor therapy represents a significant advance in cancer care. The interaction between PD-1 and PD-L1 induces immune tolerance and the inhibition of this interaction is an effective treatment strategy for numerous malignancies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::befb38bcf4f60c643c910a11decc276d
https://doi.org/10.2217/fon-2022-0392
https://doi.org/10.2217/fon-2022-0392
Autor:
Hiroko Miyagi, Elizabeth Kwenda, Brian H. Ramnaraign, Jonathan A. Chatzkel, Wayne G. Brisbane, Padraic O’Malley, Paul L. Crispen
Publikováno v:
Cancers. 15:168
Muscle-invasive bladder cancer is a life-threatening disease best managed with multimodal therapy. Neoadjuvant chemotherapy prior to cystectomy significantly improves survival with the greatest benefit noted in patients with a complete pathologic res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5476e9fac2aed6d57efe6700be344829
https://doi.org/10.3390/cancers15010168
https://doi.org/10.3390/cancers15010168